Long-COVID symptom monitoring: Insights from a two-year telemedicine study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307834 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Andrea Foppiani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food, Environmental and Nutritional Sciences (DeFENS), International Center for the Assessment of Nutritional Status (ICANS), Universit…. Hauptthemen laut MEDLINE: COVID-19, Telemedicine, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The diverse manifestations of Long-COVID have become increasingly important due to their significant impact on patients’ lives. Telemedicine has emerged as an important tool for post COVID-19 follow-up. This study is part of a large cohort study involving COVID-positive patients monitored by the COD19 telemedicine platform operations center. We recontacted patients who were initially monitored from February 2020 to May 2020 to assess the presence of Long-COVID symptoms at a 2-year follow-up.
Methods
We conducted interviews to evaluate Long-COVID symptoms at the 2-year mark and investigated whether patients had contracted a second COVID-19 infection between the 1-year and 2-year follow-ups, and recorded their vaccination status.
Results
Out of 165 patients, 139 (84%) reported symptoms at the 1-year follow-up, while only 101 (61%) reported symptoms at the 2-year follow-up. Among patients with Long-COVID symptoms at the 2-year follow-up, the majority (80, 49%) had experienced Long-COVID at the 1-year follow-up, received the SARS-CoV-2 vaccine, and had not experienced a second infection between the two follow-ups. Both having Long-COVID at the 1-year follow-up and contracting a second infection were significant risk factors for presenting with Long-COVID at the 2-year follow-up.
Conclusions
To the best of our knowledge, this study stands out as one of the few that includes a 2-year follow-up on Long-COVID symptoms using telemedicine. Telemedicine has proven to be an effective and innovative tool for long-term patient monitoring, early diagnosis, and treatment. Telemedicine represents a significant future challenge for healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Food, Environmental and Nutritional Sciences (DeFENS), International Center for the Assessment of Nutritional Status (ICANS), University of Milan, Milan, Italy.
- Department of Endocrine and Metabolic Medicine, Clinical Nutrition Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.
- Department of Biomedical and Clinical Science, University of Milan, Milan, Italy.
- Pediatric Department, "V. Buzzi" Children's Hospital, Milan, Italy.
- Orthopaedics and Traumatology, University of Milan, Milan, Italy.
- Department of Internal Medicine, University of Pavia, Pavia, Italy.
ORCID-Profile: Sara Zanelli, Valeria Calcaterra
Zitieren
APA
Foppiani, A., Montanari, C., Zanelli, S., Lombardo, M. D. M., Calcaterra, V., & Zuccotti, G. (2024). Long-COVID symptom monitoring: Insights from a two-year telemedicine study. PLOS ONE. https://doi.org/10.1371/journal.pone.0307834
Vancouver
Foppiani A, Montanari C, Zanelli S, Lombardo MDM, Calcaterra V, Zuccotti G. Long-COVID symptom monitoring: Insights from a two-year telemedicine study. PLOS ONE. 2024. doi:10.1371/journal.pone.0307834
BibTeX
@article{Foppiani2024,
author = {Foppiani, Andrea and Montanari, Chiara and Zanelli, Sara and Lombardo, Michele Davide Maria and Calcaterra, Valeria and Zuccotti, Gianvincenzo},
title = {Long-COVID symptom monitoring: Insights from a two-year telemedicine study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307834}
}
EUVIMED